2014
DOI: 10.4314/tjpr.v13i2.1
|View full text |Cite
|
Sign up to set email alerts
|

Modulatory Effect of Phytoestrogens and Curcumin on Induction of Annexin 1 in Human Peripheral Blood Mononuclear Cells and their Inhibitory Effect on Secretory Phospholipase A<sub>2</sub>

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 23 publications
0
5
0
Order By: Relevance
“…Castro-Caldas et al reported that dexamethasone and 17β-estradiol promoted ANXA1 secretion in acute T lymphoblastic leukemia cells, CCRF-CEM [28]. Ahmad et al showed that phytoestrogens induced the production of Annexin A1 in peripheral blood mononuclear cells (PBMC) [29]. However, the underlying mechanism of phytoestrogens that modulate ANXA1 and regulate these processes is still not fully understood.…”
Section: Introductionmentioning
confidence: 99%
“…Castro-Caldas et al reported that dexamethasone and 17β-estradiol promoted ANXA1 secretion in acute T lymphoblastic leukemia cells, CCRF-CEM [28]. Ahmad et al showed that phytoestrogens induced the production of Annexin A1 in peripheral blood mononuclear cells (PBMC) [29]. However, the underlying mechanism of phytoestrogens that modulate ANXA1 and regulate these processes is still not fully understood.…”
Section: Introductionmentioning
confidence: 99%
“…tion, DNA replication, cell transformation, ion channel formation, and mediation of cell proliferation, differentiation and apoptosis (7,9,10). Ahmad et al (2014) have shown that production of ANXA1 in PBMC can be induced by curcumin and phytoestrogens (11). ANXA1 has been vastly studied for its anti-inflammatory properties, but little is known about its anticancer effects, including its effect on leukemia.…”
mentioning
confidence: 99%
“…Although, it has shown many excellent pharmacological activities in in vitro experiments such as antioxidant, antiinflammatory, anti-microbial and also anti-tumor activities [1][2][3][4], curcumin has not yet been approved for use as a drug due to the very low bioavailability obtained after curcumin oral administration, which is due, in part, to poor solubility (11 ng/mL in aqueous buffer, pH 5.5 [5]) and stability (t 1/2 of curcumin in PBS pH 7.2, < 10 min [6]). Many attempts have been made to solve these problems.…”
Section: Introductionmentioning
confidence: 99%